Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : A US National Health Care System? -- Ignore unavailable to you. Want to Upgrade?

To: John Koligman who wrote (5500)	4/20/2008 12:05:20 PM
From: Lane3	Read Replies (1) \| Respond to of 42652

I tried to post an accompanying graphic Do you have a link?

To: John Koligman who wrote (5500)	4/20/2008 12:41:27 PM
From: TimF	Read Replies (1) \| Respond to of 42652

The problem with reducing profit of drug companies is that it isn't a free lunch. It isn't even a lunch that just the drug companies pay for. Reduce the expected profit and you reduce investment in the endeavor. Now some people would argue that a reduction in future drug research would be worth it. I tend to disagree, but worth it or not, the cost has to be acknowledged.